Your State:
Bookmark the new Broker Launchpad – guiding you to the right tool at the right time.
With 5 being the highest, how would you rate your experience on a scale of 1-5?
Jan 31, 2022
We now cover the oral antiviral drugs Paxlovid and Lagevrio at no additional cost to members as part of their pharmacy benefits. Both drugs received emergency use authorization from the U.S. Food and Drug Administration (FDA) late last year. They are only available by prescription and can reduce the chance of hospitalization and potential for severe illness when taken within five days after symptoms appear.
During the Coronavirus Public Health Emergency, the federal government will pay the ingredient drug costs of FDA-authorized COVID-19 oral antivirals. Employers will not have to pay the ingredient drug costs and members will have no cost share for these drugs. Claims for COVID-19 oral antivirals will be excluded from rebate calculations and other client pricing guarantees for ASO clients.
This coverage will continue for the length of the public health emergency and is retroactive to the date of FDA authorization.
Coverage limitations:
Please contact your sales representative for more information.
A Federal rule finalized on March 28 modifies the requirements for Short Term Plans. These rules limit the length of time Short Term Plans can remain in place with effective dates after September 1, 2024. This impacts the sales and renewals of our Anthem Enhanced Choice (AEC) plans. Selling n...
Small Businesses are the engine that drives communities across America. This month we honor and celebrate those businesses and commit to our continuing collaboration to build healthy communities where people and businesses thrive. We recently shared this small-business video with your client gro...